Free worldwide shipping on every order

Medical Disclaimer

This information is for educational purposes only and is not intended as medical advice. Red light therapy is not a substitute for professional medical treatment. Always consult your healthcare provider before starting any new therapy, especially for diagnosed medical conditions.

Red Light Therapy for Fibromyalgia

Red light therapy for fibromyalgia

Yeh 2019 meta-analysis (9 RCTs, n=325) concluded LLLT is effective, safe, and well-tolerated for fibromyalgia with significant improvements in FIQ, pain, tender points, fatigue, stiffness, depression, and anxiety. Son 2025 umbrella review identified fibromyalgia as the strongest-evidence endpoint for PBM across the conditions reviewed.

Evidence
Moderate
Dose
2-6 J per tender point (typically 18 tender points); whole-body PBMT bed protocols deliver larger total energy J/cm²
Wavelengths
670, 780, 808, 830, 904 nm
Frequency
2-3×/wk

TL;DR

Yes, red light therapy for fibromyalgia may help some people. It is best used as a consistent photobiomodulation routine alongside diagnosis-led care, rehab, sleep, and lifestyle basics.

Evidence-backed quick protocol

Photobiomodulation research supports plausible effects on cellular energy, nitric oxide signaling, pain mediators, and inflammatory balance for this use case [Gur 2002, PMID:12215864; Hamblin 2017, PMID:28748217]. Match wavelength depth, treatment area, and irradiance before judging results.

  1. Target the full tissue field: Treat the symptomatic area plus nearby muscles, tendons, joints, or nerve pathway.
  2. Start repeatably: Use 10-20 minutes per area, 3-5 times weekly for 4-8 weeks unless your clinician advises otherwise.
  3. Track function: Measure pain, stiffness, sleep, range of motion, and return-to-activity instead of one-session changes.
  4. Choose enough coverage: Consider RLPRO 1200 for practical home coverage, and compare context in home vs clinic red light therapy.

For adjacent symptoms, compare this guide with sleep disorders.

Understanding Fibromyalgia

Fibromyalgia is a chronic condition characterised by widespread musculoskeletal pain, fatigue, sleep disturbances, cognitive difficulties ("fibro fog"), and heightened sensitivity to sensory stimuli. It affects approximately 2–4% of the population, with a higher prevalence in women. The condition is now understood to involve central sensitisation — an amplification of pain signals within the central nervous system.

Fibromyalgia is often accompanied by other conditions including irritable bowel syndrome, temporomandibular joint disorders, migraines, and mood disorders. Current treatments include medications (pregabalin, duloxetine, milnacipran), exercise, cognitive behavioural therapy, and sleep hygiene. Many patients require a multimodal approach and continue to seek complementary therapies for better symptom management.

How Red Light Therapy May Help

Photobiomodulation may address multiple aspects of fibromyalgia through its systemic effects:

  • Pain modulation: PBM may influence peripheral pain pathways by modulating nerve conduction and reducing the sensitisation of nociceptors, potentially helping to "turn down" the amplified pain signalling characteristic of fibromyalgia.
  • Mitochondrial support: Research has identified mitochondrial dysfunction in fibromyalgia patients. PBM's primary mechanism — enhancing mitochondrial ATP production — may help address this underlying bioenergetic deficit.
  • Anti-inflammatory effects: While fibromyalgia is not a classic inflammatory condition, elevated levels of neuroinflammatory markers have been identified. PBM may help modulate these neuro-inflammatory processes.
  • Sleep improvement: PBM may influence circadian rhythm regulation and melatonin production, potentially improving the disrupted sleep patterns common in fibromyalgia.
  • Mood support: Some research suggests PBM may positively influence brain neurochemistry, including serotonin pathways, which are implicated in both pain and mood in fibromyalgia.

What the Research Says

A 2012 randomised controlled trial published in Rheumatology International studied 40 women with fibromyalgia and found that those receiving LLLT showed significant improvements in pain, number of tender points, fatigue, morning stiffness, and the Fibromyalgia Impact Questionnaire (FIQ) score compared with placebo. Benefits persisted at 6-week follow-up.

A 2019 study published in Lasers in Medical Science examined PBM applied to tender points in 48 fibromyalgia patients and reported a 30% reduction in pain scores and a significant improvement in physical function. The researchers noted that PBM was well tolerated with no adverse effects.

A comprehensive 2021 systematic review in Physiotherapy Theory and Practice concluded that PBM shows "promising results" for fibromyalgia pain and functional outcomes, though the authors called for larger, multi-centre trials with standardised protocols.

Full-Body vs. Targeted Treatment

Given that fibromyalgia involves widespread pain, many clinicians favour full-body PBM protocols that treat large areas of the body simultaneously. This approach may also harness potential systemic benefits including improved sleep and energy levels.

Recommended Usage Protocol

  • Full-body sessions: 15–20 minutes, treating front and back of the body.
  • Distance: 15–30 cm from the body.
  • Frequency: 4–5 sessions per week for the first 8 weeks, then 2–3 sessions per week for maintenance.
  • Timing: Evening sessions (1–2 hours before bed) may support sleep quality.
  • Tender points: Additional targeted treatment of specific tender points as needed.

Which Hale Panel Is Best for Fibromyalgia?

Fibromyalgia's widespread nature calls for broad coverage. The RLPRO 1200 (864 LEDs, 184 × 42 cm) is ideal for individual full-body treatment at home. For clinical settings or users who want maximum coverage efficiency, the RLPRO 2000 (1,152 LEDs, 189 × 58 cm) provides the widest treatment area available, allowing front or back coverage in a single session.

A Multimodal Approach to Fibromyalgia

  • Regular gentle exercise (walking, swimming, yoga, tai chi) — one of the most evidence-based interventions
  • Sleep hygiene: consistent sleep schedule, dark room, limiting screen time before bed
  • Stress management: meditation, breathing exercises, mindfulness
  • Pacing activities to avoid boom-bust cycles
  • Cognitive behavioural therapy for pain management
  • Medications as prescribed by your healthcare team

Red light therapy may provide fibromyalgia patients with a gentle, non-invasive modality that addresses pain, energy, and sleep — three of the condition's most challenging symptoms — without adding to the medication burden.

Frequently Asked Questions

Does red light therapy for fibromyalgia work?

red light therapy for fibromyalgia may help some people, especially when the target tissue, wavelength depth, and session schedule are consistent. It is not a guaranteed cure and should not replace medical evaluation.

How often should I use red light therapy for fibromyalgia?

A practical starting point is 3-5 sessions per week for 4-8 weeks. Use the same distance and time so changes in pain, stiffness, sleep, or function are easier to interpret.

Which wavelengths matter for fibromyalgia?

Red wavelengths are useful for superficial tissue, while near-infrared wavelengths are more relevant for deeper joints, muscles, tendons, and nerve pathways. Coverage and dose matter as much as wavelength names.

Can red light therapy for fibromyalgia replace treatment?

No. Use PBM as a complementary tool. Keep prescribed medications, rehab plans, wound care, and specialist follow-up in place unless your healthcare provider changes them.

Calculate your protocol

Get a fibromyalgia protocol calibrated to your Hale panel

Free tool. Pick your condition, get the recommended wavelength split, session time, and J/cm² target — all based on measured Hale panel irradiance.

Recommended Hale Panels

Panels best suited for fibromyalgia treatment. Health Canada Class II & FDA-listed, with 8 wavelengths (630–1060 nm).

Evidence reference

Fibromyalgia is one of 27 conditions in Hale's PBM Dose Canonical Table — a peer-reviewed-evidence-sourced reference document with the consensus dose range, wavelengths, and protocol parameters cited to verifiable PMIDs.

See the row for fibromyalgia